Clinical Trial

Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical study is to learn about the diagnostic effectiveness, safety, and influencing factors of transbronchial cryobiopsy（TBLC）in progressive pulmonary fibrosis. The main question it aims to answer are: • Determine the prognosis, health economics, and therapeutic strategy changes of patients with TBLC retrograde malleable pulmonary fibrosis. Participants will be randomly divided into two groups, and received TBLB or TBLC.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-01.
Status change: Not Yet Recruiting → Recruiting 2025-02-07
Trial Details
NCT Number NCT06251687
Lead Sponsor China-Japan Friendship Hospital
Conditions Pulmonary Fibrosis, Transbronchial Cryobiopsy
Enrollment 100 participants
Start Date 2024-02-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-10